1,617€
3,09%
Echtzeit-Aktienkurs Tilray Brands Inc.
Bid:
Ask:
Echtzeit-Chart der Tilray Brands Inc. Aktie
Börsenkurse Tilray Brands Inc.
| Nasdaq | - | - | - | - | 1,738$ | 3,45% |
| Lang & Schwarz | - | - | - | - | 1,622€ | 3,94% |
| BERN | - | - | - | - | 1,58CHF | 2,73% |
| Börse Frankfurt | - | - | - | - | 1,588€ | 2,92% |
| Börse Stuttgart | - | - | - | - | 1,617€ | 3,19% |
| Tradegate | - | - | - | - | 1,617€ | 3,09% |
| Xetra | - | - | - | - | 1,589€ | -0,25% |
| gettex | - | - | - | - | 1,625€ | 3,83% |
| Echtzeit Euro | - | - | - | - | 1,617€ | 3,09% |
| Echtzeit USD | - | - | - | - | 1,720$ | 2,36% |
Fundamentaldaten der Tilray Brands Inc. Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2022 [USD] | 628,37 Mio. | -440,67 Mio. | -476,80 Mio. | -0,99 | - | - | 1,59 |
| 2021 [USD] | 513,09 Mio. | -344,53 Mio. | -367,42 Mio. | -1,36 | - | - | 1,41 |
| 2020 [USD] | 210,48 Mio. | -270,69 Mio. | -271,07 Mio. | -2,15 | - | - | 1,22 |
| 2019 [USD] | 166,98 Mio. | -325,12 Mio. | -321,17 Mio. | -3,20 | - | - | 1,00 |
| 2018 [USD] | 43,13 Mio. | -72,17 Mio. | -67,72 Mio. | -0,82 | - | - | 3,49 |
| 2017 [USD] | 20,54 Mio. | -7,81 Mio. | -7,81 Mio. | -0,08 | - | - | 7,33 |
| 2016 [USD] | 12,64 Mio. | -7,88 Mio. | -7,88 Mio. | -0,09 | - | - | 11,74 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der Tilray Brands Inc. Aktie
Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.